Spots Global Cancer Trial Database for benign prostatic hyperplasia
Every month we try and update this database with for benign prostatic hyperplasia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Economic Analyses of the REDUCE Trial | NCT01337258 | Neoplasms, Pros... Benign Prostati... Cancer | Dutasteride Placebo | 50 Years - 75 Years | GlaxoSmithKline | |
| Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship | NCT03479359 | Prostatic Neopl... Digital Rectal ... Benign Prostati... | Routine review ... | - | Changhai Hospital | |
| 2013 Annual National Digital Rectal Exam (DRE) Day Study | NCT01886547 | Benign Prostati... Prostatitis Prostate Cancer | Prostate health... | 40 Years - | St. Luke's Medical Center, Philippines | |
| Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma | NCT00400894 | Prostate Cancer Benign Prostati... Prostatic Intra... | - | ProteoSys AG | ||
| Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) | NCT01250483 | Benign Prostati... Prostate Cancer | PSA measurement... | 40 Years - 80 Years | Seoul National University Hospital | |
| Rezum I Pilot Study for Benign Prostatic Hyperplasia | NCT02943070 | Prostatic Hyper... Benign Prostati... Adenoma, Prosta... Prostatic Adeno... Prostatic Hyper... Prostatic Hyper... Prostatic Hyper... Rezum | Rezum System | 45 Years - | Boston Scientific Corporation | |
| PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs | NCT06051942 | Benign Prostati... Localized Prost... | Robotic Waterje... | - 80 Years | PROCEPT BioRobotics | |
| Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels | NCT01678313 | Benign Prostati... | Doxazosin 4 mg ... Doxazosin 4 mg ... | 40 Years - | Buddhist Tzu Chi General Hospital | |
| Anti-Androgen Treatment for COVID-19 | NCT04446429 | COVID-19 SARS-CoV2 Androgenetic Al... Prostate Cancer Benign Prostati... SARS (Severe Ac... | Proxalutamide Standard of Car... | 18 Years - | Applied Biology, Inc. | |
| Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain | NCT05803096 | Prostate Diseas... Malignancy Benign Prostati... Prostate Cancer Prostate Adenoc... Anxiety and Fea... Pain | Self-Administer... Oxygen | 18 Years - 85 Years | Beth Israel Deaconess Medical Center | |
| Korean Practice Patterns for Screening PCA(Prostate Cancer) | NCT01371513 | Neoplasms, Pros... Prostate Cancer Benign Prostati... | continuous scre... | 40 Years - | GlaxoSmithKline | |
| Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia | NCT06380062 | Primary Prostat... Benign Prostati... | Plasma concentr... | 50 Years - | Universität des Saarlandes | |
| Application of DWI in Diagnosis of Prostate Cancer | NCT04962269 | Prostate Cancer Benign Prostati... | MRI | - | Peking University Third Hospital | |
| MRI Guided Transurethral HIFU for Various Prostate Diseases | NCT03350529 | Localised Prost... Locally Advance... Locally Recurre... Benign Prostati... | MRI guided tran... | - | Turku University Hospital | |
| To Evaluate LUTS and Complications Between Indwelling Catheter and Temporary Prostatic Stent in Patients Undergoing Minimally Invasive Procedures for the Treatment of Localized Prostate Cancer or Benign Prostatic Hyperplasia (HERMES) | NCT05851521 | Lower Urinary T... Prostatic Hyper... Prostatic Cance... Urinary Retenti... | Temporary prost... Indwelling cath... | 18 Years - 85 Years | Lyx Institute | |
| BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) | NCT01520441 | Prostate Cancer Benign Prostati... Enlarged Prosta... | BOTOX | 50 Years - | The University of Texas Health Science Center, Houston | |
| Rezum I Pilot Study for Benign Prostatic Hyperplasia | NCT02943070 | Prostatic Hyper... Benign Prostati... Adenoma, Prosta... Prostatic Adeno... Prostatic Hyper... Prostatic Hyper... Prostatic Hyper... Rezum | Rezum System | 45 Years - | Boston Scientific Corporation | |
| Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia | NCT05314582 | Hematuria Retention, Urin... Operative Bleed... Blood Transfusi... | - | Bezmialem Vakif University | ||
| Anti-Androgen Treatment for COVID-19 | NCT04446429 | COVID-19 SARS-CoV2 Androgenetic Al... Prostate Cancer Benign Prostati... SARS (Severe Ac... | Proxalutamide Standard of Car... | 18 Years - | Applied Biology, Inc. | |
| Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer. | NCT05148156 | Benign Prostati... | Urolift | 40 Years - 99 Years | Weill Medical College of Cornell University | |
| BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) | NCT01520441 | Prostate Cancer Benign Prostati... Enlarged Prosta... | BOTOX | 50 Years - | The University of Texas Health Science Center, Houston | |
| MRI Guided Transurethral HIFU for Various Prostate Diseases | NCT03350529 | Localised Prost... Locally Advance... Locally Recurre... Benign Prostati... | MRI guided tran... | - | Turku University Hospital | |
| MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer | NCT00706966 | Nonmalignant Ne... Prostate Cancer | dutasteride | - | University of California, San Francisco | |
| Application of DWI in Diagnosis of Prostate Cancer | NCT04962269 | Prostate Cancer Benign Prostati... | MRI | - | Peking University Third Hospital | |
| Rezum FIM Optimization Study | NCT02940392 | Benign Prostati... Adenoma, Prosta... Prostatic Adeno... Prostatic Hyper... Prostatic Hyper... Prostatic Hyper... Rezum | Rezum System | 45 Years - | Boston Scientific Corporation | |
| Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate | NCT00632138 | Nonmalignant Ne... Prostate Cancer Psychosocial Ef... Sexual Dysfunct... Urinary Inconti... | exercise interv... questionnaire a... biofeedback management of t... psychosocial as... quality-of-life... | - | National Cancer Institute (NCI) | |
| Application of DWI in Diagnosis of Prostate Cancer | NCT04962269 | Prostate Cancer Benign Prostati... | MRI | - | Peking University Third Hospital | |
| ARI103094-Follow-Up Study for REDUCE Study Subjects | NCT00883909 | Neoplasms, Pros... | dutasteride | 50 Years - | GlaxoSmithKline | |
| Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization | NCT04879940 | Prostate Carcin... Benign Prostati... | Merit Medical E... Radiation Thera... | 50 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) | NCT01250483 | Benign Prostati... Prostate Cancer | PSA measurement... | 40 Years - 80 Years | Seoul National University Hospital | |
| Korean Practice Patterns for Screening PCA(Prostate Cancer) | NCT01371513 | Neoplasms, Pros... Prostate Cancer Benign Prostati... | continuous scre... | 40 Years - | GlaxoSmithKline | |
| Rezum FIM Optimization Study | NCT02940392 | Benign Prostati... Adenoma, Prosta... Prostatic Adeno... Prostatic Hyper... Prostatic Hyper... Prostatic Hyper... Rezum | Rezum System | 45 Years - | Boston Scientific Corporation | |
| Application of DWI in Diagnosis of Prostate Cancer | NCT04962269 | Prostate Cancer Benign Prostati... | MRI | - | Peking University Third Hospital | |
| Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate | NCT02822963 | Benign Prostati... Prostate Cancer | 20 Years - | National Cheng-Kung University Hospital | ||
| Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain | NCT05803096 | Prostate Diseas... Malignancy Benign Prostati... Prostate Cancer Prostate Adenoc... Anxiety and Fea... Pain | Self-Administer... Oxygen | 18 Years - 85 Years | Beth Israel Deaconess Medical Center | |
| Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate | NCT00632138 | Nonmalignant Ne... Prostate Cancer Psychosocial Ef... Sexual Dysfunct... Urinary Inconti... | exercise interv... questionnaire a... biofeedback management of t... psychosocial as... quality-of-life... | - | National Cancer Institute (NCI) | |
| 3D Recording of a Trans-rectal Prostate Biopsy | NCT01314456 | Prostate Cancer Benign Prostati... | NaviGo | 18 Years - | HaEmek Medical Center, Israel | |
| Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome | NCT01826617 | Prostate Cancer Prostatitis Benign Prostati... | 18 Years - | St. Luke's Medical Center, Philippines | ||
| Economic Analyses of the REDUCE Trial | NCT01337258 | Neoplasms, Pros... Benign Prostati... Cancer | Dutasteride Placebo | 50 Years - 75 Years | GlaxoSmithKline | |
| Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization | NCT04879940 | Prostate Carcin... Benign Prostati... | Merit Medical E... Radiation Thera... | 50 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Customized TULSA-PRO Ablation Registry | NCT05001477 | Prostate Cancer Prostate Adenoc... Benign Prostati... | TULSA Procedure | 18 Years - | Profound Medical Inc. | |
| Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells | NCT02425800 | Benign Prostati... Prostate Carcin... | Cytology Specim... Laboratory Biom... | - | Wake Forest University Health Sciences | |
| MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer | NCT00706966 | Nonmalignant Ne... Prostate Cancer | dutasteride | - | University of California, San Francisco | |
| Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer | NCT00375765 | Benign Prostati... Prostate Cancer | Dutasteride | 50 Years - | GlaxoSmithKline | |
| Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder | NCT05077852 | Bladder Cancer Benign Prostati... Hematuria | Urethrocystosco... | 18 Years - 90 Years | Ankara Training and Research Hospital | |
| Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate | NCT02822963 | Benign Prostati... Prostate Cancer | 20 Years - | National Cheng-Kung University Hospital | ||
| Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate | NCT00632138 | Nonmalignant Ne... Prostate Cancer Psychosocial Ef... Sexual Dysfunct... Urinary Inconti... | exercise interv... questionnaire a... biofeedback management of t... psychosocial as... quality-of-life... | - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
